Polymyxin B induces apoptosis in kidney proximal tubular cells

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4329-4335

  Azad, Mohammad A K ^a   Finnin, Ben A ^a   Poudyal, Anima ^a   Davis, Kathryn ^a   Li, Jian ^a   Li, Jinhua ^b   Hill, Prue A ^c   Nation, Roger L ^a   Velkov, Tony ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; POLYMYXIN B; PROPIDIUM IODIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

EID: 84882406434     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02587-12     Document Type: Article

References (59)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
2. Talbot GH, Bradley J, Edwards JE, Jr, Gilbert D, Scheld M, Bartlett JG. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42:657-668.
3. Bergen PJ, Landersdorfer CB, Zhang J, Zhao M, Lee HJ, Nation RL, Li J. 2012. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Diagn. Microbiol. Infect. Dis. 74:213-223.
4. Falagas ME, Kasiakou SK. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
5. Randall RE, Bridi GS, Setter JG, Brackett NC. 1970. Recovery from colistimethate nephrotoxicity. Ann. Intern. Med. 73:491-492.
6. Price DJ, Graham DI. 1970. Effects of large doses of colistin sulphomethate sodium on renal function. BMJ 4:525-527.
7. Kubin CJ, Ellman TM, Phadke V, Haynes LJ, Calfee DP, Yin MT. 2012. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J. Infect. 65:80-87.
8. Falagas ME, Kasiakou SK. 2006. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10:R27. doi:10.1186/cc3995.
9. Dezoti Fonseca C, Watanabe M, de Vattimo MDF. 2012. Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats. Antimicrob. Agents Chemother. 56:5082-5087.
10. Elias LS, Konzen D, Krebs JM, Zavascki AP. 2010. The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic. J. Antimicrob. Chemother. 65:2231-2237.
11. Kvitko CH, Rigatto MH, Moro AL, Zavascki AP. 2011. Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia. J. Antimicrob. Chemother. 66:175-179.
12. Pastewski AA, Caruso P, Parris AR, Dizon R, Kopec R, Sharma S, Mayer S, Ghitan M, Chapnick EK. 2008. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series. Ann. Pharmacother. 42:1177-1187.
13. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. 2006. Colistin: the re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
14. Abdelraouf K, Braggs KH, Yin T, Truong LD, Hu M, Tam VH. 2012. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob. Agents Chemother. 56:4625-4629.
15. Wallace SJ, Li J, Nation RL, Rayner CR, Taylor D, Middleton D, Milne RW, Coulthard K, Turnidge JD. 2008. Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. Antimicrob. Agents Chemother. 52:1159-1161.
16. Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A. 2005. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int. J. Antimicrob. Agents 26:504-507.
17. Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, Vishnepolsky M, Weintrob A, Wortmann G. 2009. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin. Infect. Dis. 48:1724-1728.
18. Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob. Agents Chemother. 47:1766-1770.
19. Zavascki AP, Goldani LZ, Cao GY, Superti SV, Lutz L, Barth AL, Ramos F, Boniatti MM, Nation RL, Li J. 2008. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin. Infect. Dis. 47:1298-1304.
20. Ozyilmaz E, Ebinc FA, Derici U, Gulbahar O, Goktas G, Elmas C, Oguzulgen IK, Sindel S. 2011. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med. 37: 141-146.
21. Yousef JM, Chen G, Hill PA, Nation RL, Li J. 2012. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J. Antimicrob. Chemother. 67:452-459.
22. Yousef JM, Chen G, Hill PA, Nation RL, Li J. 2011. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob. Agents Chemother. 55:4044-4049.
23. Jacobson MD, Weil M, Raff MC. 1997. Programmed cell death in animal development. Cell 88:347-354.
24. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407: 770-776.
25. Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S. 1999. Apoptosis: cell death defined by caspase activation. Cell Death Differ. 6:495-496.
26. Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257.
27. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
28. Brenner C, Kroemer G. 2000. Apoptosis. Mitochondria-the death signal integrators. Science 289:1150-1151.
29. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
30. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR. 1996. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:28753-28756.
31. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. 1998. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5:551-562.
32. Balasubramanian K, Schroit AJ. 1998. Characterization of phosphatidylserine-dependent beta(2)-glycoprotein I macrophage interactions: implications for apoptotic cell clearance by phagocytes. J. Biol. Chem. 273: 29272-29277.
33. Verga Falzacappa C, Mangialardo C, Madaro L, Ranieri D, Lupoi L, Stigliano A, Torrisi MR, Bouche M, Toscano V, Misiti S. 2011. Thyroid hormone T3 counteracts STZ induced diabetes in mouse. PLoS One 6:e19839. doi:10.1371/journal.pone.0019839.
34. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
35. Sakahira H, Enari M, Nagata S. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99.
36. Xiong XL, Jia RH, Yang DP, Ding GH. 2006. Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. Pharmacol. Res. 54: 253-260.
37. Han KH, Lee UY, Jang YS, Cho YM, Jang YM, Hwang IA, Ghee JY, Lim SW, Kim WY, Yang CW, Kim J, Kwon OJ. 2007. Differential regulation of B/K protein expression in proximal and distal tubules of rat kidneys with ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 292: F100-F106.
38. Antonsson A, Persson JL. 2009. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/M checkpoint accompanied by alterations in Erk and Akt kinase activities. Anticancer Res. 29:2893-2898.
39. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother. 55:3284-3294.
40. Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL. 2010. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob. Agents Chemother. 54:3783-3789.
41. Dudhani RV, Turnidge JD, Nation RL, Li J. 2010. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. J. Antimicrob. Chemother. 65:1984-1990.
42. Nation RL, Li J. 2009. Colistin in the 21st century. Curr. Opin. Infect. Dis. 22:535-543.
43. Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Bordinhao RC, Wang J, Forrest A, Nation RL, Li J, Zavascki AP. 23 June 2013. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin. Infect. Dis. doi:10.1093/cid/cit334.
44. Chen YC, Chen CH, Hsu YH, Chen TH, Sue YM, Cheng CY, Chen TW. 2011. Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. Eur. J. Pharmacol. 658:213-218.
45. Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez-Hernandez FJ. 2011. An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol. Sci. 119:245-256.
46. Wei Q, Dong G, Franklin J, Dong Z. 2007. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 72:53-62.
47. Taneda S, Honda K, Tomidokoro K, Uto K, Nitta K, Oda H. 2010. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. Am. J. Physiol. Renal Physiol. 299:F1451-F1461.
48. Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW. 2010. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats. Am. J. Physiol. Renal Physiol. 298:F301-F313.
49. Mingeot-Leclercq MP, Tulkens PM, Denamur S, Vaara T, Vaara M. 2012. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells. Peptides 35:248-252.
50. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nunez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G. 2009. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 16:1093-1107.
51. Girton RA, Sundin DP, Rosenberg ME. 2002. Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. Am. J. Physiol. Renal Physiol. 282:F703-F709.
52. Jo SK, Cho WY, Sung SA, Kim HK, Won NH. 2005. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 67:458-466.
53. Servais H, Van Der Smissen P, Thirion G, Van der Essen G, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP. 2005. Gentamicininduced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol. Appl. Pharmacol. 206:321-333.
54. Cryns V, Yuan J. 1998. Proteases to die for. Genes Dev. 12:1551-1570.
55. Feingold DS, HsuChen CC, Sud IJ. 1974. Basis for the selectivity of action of the polymyxin antibiotics on cell membranes. Ann. N. Y. Acad. Sci. 235:480-492.
56. Kunin CM. 1970. Binding of antibiotics to tissue homogenates. J. Infect. Dis. 121:55-64.
57. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
58. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wekerle H, Lassmann H. 1993. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J. Histochem. Cytochem. 41:1023-1030.
59. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420.